𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The possible role of factor H in colon cancer resistance to complement attack

✍ Scribed by Ewa Wilczek; Robert Rzepko; Dominika Nowis; Magdalena Legat; Jakub Golab; Marta Glab; Adam Gorlewicz; Filip Konopacki; Michal Mazurkiewicz; Dariusz Sladowski; Barbara Gornicka; Aleksander Wasiutynski; Grzegorz M. Wilczynski


Publisher
John Wiley and Sons
Year
2008
Tongue
French
Weight
612 KB
Volume
122
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

A soluble complement inhibitor factor H (FH) and its splice variant factor H‐like protein (FHL) have been recently discovered to play a major role in malignant cell escape from complement‐mediated cytotoxicity in lung‐, ovarian‐ and glia‐derived neoplasms. The role of FH in colon cancer has not yet been examined. Here, we studied immunocytochemically FH/FHL expression in tumor samples derived from 40 patients, with both primary colon adenocarcinoma and metastatic foci in the liver. FH/FHL immunoreactivity was present in stroma of both primary and metastatic tumors, in virtually all patients. The cellular immunoreactivity was observed infrequently. Importantly, when analyzed quantitatively, FH/FHL immunoreactivity was significantly increased in liver metastases when compared with the primary sites. In addition, we have analyzed FH and FHL expression in 5 colon cancer cell lines: SW480, SW620, HCT116, HT‐29 and Lovo. FH mRNA and FH secretion were observed in SW620 and HT‐29 cells, whereas FHL was produced only by HT‐29 cell‐line. By confocal and electron microscopy, FH immunoreactivity was associated with the plasma membrane and intracellular vesicular structures. Finally, we have analyzed the role of FH in the susceptibility of SW620 colon cancer cells to complement‐mediated damage. When FH function was blocked, using specific antibody, the cells became more susceptible to lysis. Taken together, our results suggest an important role of FH/FHL in colon cancer cells defense against complement‐mediated cytotoxicity, and in metastatic process. © 2008 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


The role of colon anaerobes in the metab
✍ Michael J. Hill 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 675 KB

The principle enzymes in the metabolism of both the substituent groups and the nucleus of the bile acids and of cholesterol are reviewed, together with their possible relevence to the etiology of large bowel cancer. Since the incidence of the disease appears to be related to the bile acid concentrat

Intrinsic resistance to apoptosis of col
✍ Karine Oumouna-Benachour; Mustapha Oumouna; Mourad Zerfaoui; Chetan Hans; Kennet 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB

## Abstract Alterations in the delicate balance between cell proliferation and cell death disrupt colon homeostasis and serve as determining factors in colon tumorigenesis. The two mouse strains, AKR/J (resistant) and A/J (susceptible), have been widely used as models for dimethylhydrazine‐induced

Na+/H+ exchanger activity is increased i
✍ Erica Miraglia; Daniele Viarisio; Chiara Riganti; Costanzo Costamagna; Dario Ghi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 141 KB 👁 1 views

## Abstract Multidrug resistant (MDR) tumor cells exhibit an altered pH gradient across different cell compartments, which favors a reduced intracellular accumulation of antineoplastic drugs and a decreased therapeutic effect. In our study, we have observed that the activity and expression of Na^+^

Green tea polyphenols potentiate the act
✍ Usha Gundimeda; Thomas H. McNeill; Jason E. Schiffman; David R. Hinton; Rayudu G 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 795 KB

## Abstract Exogenously administered nerve growth factor (NGF) repairs injured axons, but it does not cross the blood–brain barrier. Thus, agents that could potentiate the neuritogenic ability of endogenous NGF would be of great utility in treating neurological injuries. Using the PC12 cell model,